U.S. FDA's banner
U.S. FDA's profile picture

U.S. FDA

@US_FDA • 590,642 subscribers

Our posts are FDA Approved! Privacy Policy - https://t.co/LbTJXYRXVP FDA Authentic Accounts - https://t.co/w2LNbzG7M0

Shorts

FDA has issued 7 warning letters linked to 20+ violative products with concerns about GLP-1 and other products sold to consumers marked for “research purposes” or “not for human consumption”. These products may pose serious health risks. Do not use or purchase unapproved GLP-1 products marketed for research purposes.

FDA has issued 7 warning letters linked to 20+ violative products with concerns about GLP-1 and other products sold to consumers marked for “research purposes” or “not for human consumption”. These products may pose serious health risks. Do not use or purchase unapproved GLP-1 products marketed for research purposes.

1,384,288 views

FDA proposes to exclude semaglutide, tirzepatide, and liraglutide on the 503B bulks list. After careful review, we did not identify sufficient clinical need for outsourcing facilities to compound these drugs from bulk substances. Public comment period now open. Learn more:

FDA proposes to exclude semaglutide, tirzepatide, and liraglutide on the 503B bulks list. After careful review, we did not identify sufficient clinical need for outsourcing facilities to compound these drugs from bulk substances. Public comment period now open. Learn more:

105,140 views

The U.S. FDA has issued a "safe to proceed" letter allowing the initiation of an expanded access treatment protocol (EAP) for daraxonrasib, an experimental drug targeting pancreatic cancer. Per EAP guidelines, requests must be submitted to the sponsor by U.S.-licensed physicians on behalf of eligible patients. #FDA #PancreaticCancer

The U.S. FDA has issued a "safe to proceed" letter allowing the initiation of an expanded access treatment protocol (EAP) for daraxonrasib, an experimental drug targeting pancreatic cancer. Per EAP guidelines, requests must be submitted to the sponsor by U.S.-licensed physicians on behalf of eligible patients. #FDA #PancreaticCancer

51,989 views

Today FDA approved the first-ever gene therapy for the treatment of genetic hearing loss under the National Priority Voucher Program. ✅6th approval under the National Priority Voucher Program ✅Approved 61 days after filing

Today FDA approved the first-ever gene therapy for the treatment of genetic hearing loss under the National Priority Voucher Program. ✅6th approval under the National Priority Voucher Program ✅Approved 61 days after filing

41,144 views

Today, FDA approved a medication for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), to be used along with diet and exercise.

Today, FDA approved a medication for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), to be used along with diet and exercise.

71,929 views

This Veterans Day, we thank all military veterans, including the many FDA employees who have served our nation.

This Veterans Day, we thank all military veterans, including the many FDA employees who have served our nation.

14,509 views

#DrMartinLutherKingJr once said, "Of all the forms of inequality, injustice in health is the most shocking and inhumane.” The FDA remains committed to promote and protect the health of diverse populations through research and communication of science that address health disparities. Thank you, Dr. King, for your dream and commitment to equality for all.

#DrMartinLutherKingJr once said, "Of all the forms of inequality, injustice in health is the most shocking and inhumane.” The FDA remains committed to promote and protect the health of diverse populations through research and communication of science that address health disparities. Thank you, Dr. King, for your dream and commitment to equality for all.

20,421 views

Videos

LIVE
1.2k

Anya Rossi

sweetdream.ai

SweetDream.aiSponsored•Livecam
Streaming Now

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

HD live stream
Exclusive private shows
1.2k viewers online

Free preview available • Premium content

Today, FDA provided important updates on the risk of myocarditis after receiving an mRNA COVID-19 vaccine, noting the risk is higher in young men.
15:38
US_FDA's profile picture

Today, FDA provided important updates on the risk of myocarditis after receiving an mRNA COVID-19 vaccine, noting the risk is higher in young men.

U.S. FDA

1,896,853 views • 1 year ago

Today, the FDA launched Elsa, a generative AI tool designed to help employees—from scientific reviewers to investigators—work more efficiently. This innovative tool modernizes agency functions and leverages AI capabilities to better serve the American people. Elsa in Action ➤ Accelerate clinical protocol reviews ➤ Shorten the time needed for scientific evaluations ➤ Identify high-priority inspections targets ➤ Perform faster label comparisons ➤ Summarize adverse events to support safety profile assessments ➤ Generate code to help develop databases for nonclinical applications
1:39
US_FDA's profile picture

Today, the FDA launched Elsa, a generative AI tool designed to help employees—from scientific reviewers to investigators—work more efficiently. This innovative tool modernizes agency functions and leverages AI capabilities to better serve the American people. Elsa in Action ➤ Accelerate clinical protocol reviews ➤ Shorten the time needed for scientific evaluations ➤ Identify high-priority inspections targets ➤ Perform faster label comparisons ➤ Summarize adverse events to support safety profile assessments ➤ Generate code to help develop databases for nonclinical applications

U.S. FDA

474,598 views • 1 year ago

Today, the FDA announced its Commissioner’s National Priority Voucher program to accelerate the delivery of crucial treatments to the American public.
2:18
US_FDA's profile picture

Today, the FDA announced its Commissioner’s National Priority Voucher program to accelerate the delivery of crucial treatments to the American public.

U.S. FDA

455,609 views • 1 year ago

FDA Commissioner Makary sits down for a conversation with the newly appointed director of the Center for Biologics Evaluation and Research (CBER) Dr. Vinayak “Vinay” Kashyap Prasad and Sanjula Jain-Nagpal, Associate Director of Policy & Research Strategy, Office of the Commissioner (OC). The trio talks about the current and future happenings at the FDA.
22:46
US_FDA's profile picture

FDA Commissioner Makary sits down for a conversation with the newly appointed director of the Center for Biologics Evaluation and Research (CBER) Dr. Vinayak “Vinay” Kashyap Prasad and Sanjula Jain-Nagpal, Associate Director of Policy & Research Strategy, Office of the Commissioner (OC). The trio talks about the current and future happenings at the FDA.

U.S. FDA

462,667 views • 1 year ago

The FDA is moving at LIGHT SPEED ⚡️🇺🇸 ✅ Cutting red tape on BIOSIMILARS to lower costs for your family ✅ MAHA Mission for supplement safety ✅ STOPPING the Screwworm parasite ✅ 1K+ NEW JOBS for top scientists ✅ Launching AEMS to modernize safety and save taxpayer dollars
1:45
US_FDA's profile picture

The FDA is moving at LIGHT SPEED ⚡️🇺🇸 ✅ Cutting red tape on BIOSIMILARS to lower costs for your family ✅ MAHA Mission for supplement safety ✅ STOPPING the Screwworm parasite ✅ 1K+ NEW JOBS for top scientists ✅ Launching AEMS to modernize safety and save taxpayer dollars

U.S. FDA

99,683 views • 4 months ago

In 2025, the FDA implemented an agenda of bold reforms. We made a lot of progress — and we're just getting started.
1:30
US_FDA's profile picture

In 2025, the FDA implemented an agenda of bold reforms. We made a lot of progress — and we're just getting started.

U.S. FDA

136,943 views • 6 months ago

It’s time to tell people the truth about food.
0:25
US_FDA's profile picture

It’s time to tell people the truth about food.

U.S. FDA

82,329 views • 6 months ago

FDA Commissioner Dr. Marty Makary talks about promising treatments in the pipeline and the innovations and breakthroughs he’d like to see in the future.
0:52
US_FDA's profile picture

FDA Commissioner Dr. Marty Makary talks about promising treatments in the pipeline and the innovations and breakthroughs he’d like to see in the future.

U.S. FDA

145,812 views • 1 year ago

This year marks the FDA’s 120th year of service to this nation. Today, we unveil the FDA's first-ever official seal—a symbol of our unwavering commitment to you.
2:51
US_FDA's profile picture

This year marks the FDA’s 120th year of service to this nation. Today, we unveil the FDA's first-ever official seal—a symbol of our unwavering commitment to you.

U.S. FDA

63,752 views • 5 months ago

🔊 New FDA Direct! Dr. Marty Makary and Dr. Prasad discuss Dr. Pazdur’s outstanding track record, CDER-CBER collaboration, and this week’s big news on HRT.
29:58
US_FDA's profile picture

🔊 New FDA Direct! Dr. Marty Makary and Dr. Prasad discuss Dr. Pazdur’s outstanding track record, CDER-CBER collaboration, and this week’s big news on HRT.

U.S. FDA

83,939 views • 8 months ago

Today, we finalized recommendations for assessing blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.
0:52
US_FDA's profile picture

Today, we finalized recommendations for assessing blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.

U.S. FDA

282,609 views • 3 years ago

FDA is taking a critical look at our food supply, using the best science and common sense.
0:39
US_FDA's profile picture

FDA is taking a critical look at our food supply, using the best science and common sense.

U.S. FDA

117,668 views • 1 year ago

Another busy week at FDA!
2:16
US_FDA's profile picture

Another busy week at FDA!

U.S. FDA

39,149 views • 4 months ago

Listen as FDA Commissioner Dr. Marty Makary discusses how the latest generation of AI was used to assist FDA with our first scientific product review.
0:58
US_FDA's profile picture

Listen as FDA Commissioner Dr. Marty Makary discusses how the latest generation of AI was used to assist FDA with our first scientific product review.

U.S. FDA

109,324 views • 1 year ago

FDA CBER Director Vinayak Prasad and Dr. Marty Makary discuss an evidence-based approach to COVID-19 vaccination.
38:36
US_FDA's profile picture

FDA CBER Director Vinayak Prasad and Dr. Marty Makary discuss an evidence-based approach to COVID-19 vaccination.

U.S. FDA

97,580 views • 1 year ago

FDA Commissioner Dr. Marty Makary with Secretary Kennedy, Jay Bhattacharya and DrOzCMS as President Donald J. Trump signs Executive Order to bring the prices Americans and taxpayers pay for prescription drugs in line with those paid by similar nations.
1:24
US_FDA's profile picture

FDA Commissioner Dr. Marty Makary with Secretary Kennedy, Jay Bhattacharya and DrOzCMS as President Donald J. Trump signs Executive Order to bring the prices Americans and taxpayers pay for prescription drugs in line with those paid by similar nations.

U.S. FDA

97,175 views • 1 year ago

FDA approved two new drugs for rare diseases this week! Learn more about these approvals and other good news:
2:06
US_FDA's profile picture

FDA approved two new drugs for rare diseases this week! Learn more about these approvals and other good news:

U.S. FDA

30,283 views • 3 months ago

In our latest FDA Direct conversation, we dive into recent policy changes: • Updates on the Commissioner’s National Priority Voucher program • Review of certain clinical trials involving foreign labs • Dr. Marty Makary insights from the BIO Conference
35:08
US_FDA's profile picture

In our latest FDA Direct conversation, we dive into recent policy changes: • Updates on the Commissioner’s National Priority Voucher program • Review of certain clinical trials involving foreign labs • Dr. Marty Makary insights from the BIO Conference

U.S. FDA

77,780 views • 1 year ago

Today, we approved the first nasal spray for the emergency treatment of allergic reactions, including life-threatening anaphylaxis, in adult and pediatric patients who weigh at least 66 pounds.
0:20
US_FDA's profile picture

Today, we approved the first nasal spray for the emergency treatment of allergic reactions, including life-threatening anaphylaxis, in adult and pediatric patients who weigh at least 66 pounds.

U.S. FDA

116,830 views • 1 year ago

In 2025 we tested 102 samples of honey for hidden sweeteners. Most honey passed the test—but even a small amount of fraud matters. We’re staying vigilant to protect the integrity of your food.
0:23
US_FDA's profile picture

In 2025 we tested 102 samples of honey for hidden sweeteners. Most honey passed the test—but even a small amount of fraud matters. We’re staying vigilant to protect the integrity of your food.

U.S. FDA

24,608 views • 3 months ago